Peptides
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (3)
- (2)
- (2)
- (1)
- (1)
- (2)
- (3)
- (2)
- (2)
- (1)
- (7)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (4)
- (1)
- (2)
- (2)
- (9)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (3)
- (1)
- (2)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (4)
- (5)
- (3)
- (3)
- (2)
- (3)
- (1)
- (1)
- (3)
- (8)
- (2)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (5)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (2)
- (4)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (3)
- (2)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (1)
- (5)
- (3)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (2)
- (2)
- (6)
- (1)
- (2)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (4)
- (1)
- (2)
- (1)
- (2)
- (6)
- (2)
- (3)
- (1)
- (1)
- (1)
- (1)
- (5)
- (1)
- (3)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (3)
- (1)
- (2)
- (2)
- (1)
- (3)
- (3)
- (1)
- (3)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (3)
- (2)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (2)
- (2)
- (2)
- (3)
- (1)
- (1)
- (1)
- (8)
- (1)
- (3)
- (2)
- (3)
- (2)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (3)
- (2)
- (1)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (2)
- (3)
- (1)
- (3)
- (4)
- (3)
- (1)
- (1)
- (3)
- (1)
- (1)
- (3)
- (3)
- (2)
- (1)
- (3)
- (2)
- (5)
- (1)
- (1)
- (1)
- (3)
- (2)
- (1)
- (3)
- (1)
- (1)
- (3)
- (2)
- (7)
- (2)
- (2)
- (3)
- (2)
- (2)
- (1)
- (4)
- (5)
- (3)
- (2)
- (2)
- (1)
- (1)
- (1)
- (5)
- (1)
- (1)
- (3)
- (2)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (4)
- (1)
- (2)
- (3)
- (1)
- (4)
- (1)
- (1)
- (3)
- (1)
- (2)
- (1)
- (6)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (3)
- (1)
- (2)
- (2)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (2)
- (1)
- (3)
- (1)
- (2)
- (2)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (5)
- (1)
- (3)
- (1)
- (5)
- (4)
- (1)
- (2)
- (1)
- (2)
- (1)
- (2)
- (1)
- (4)
- (4)
- (2)
- (2)
- (2)
- (2)
- (3)
- (1)
- (3)
- (4)
- (4)
- (4)
- (3)
- (2)
- (2)
- (1)
- (2)
- (4)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (2)
- (1)
- (6)
- (2)
- (1)
- (3)
- (5)
- (1)
- (8)
- (4)
- (1)
- (1)
- (1)
- (3)
- (1)
- (1)
- (3)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (2)
- (2)
- (1)
- (2)
- (1)
- (2)
- (1)
- (2)
- (1)
- (5)
- (2)
- (1)
- (1)
- (1)
- (2)
- (1)
- (3)
- (1)
- (3)
- (2)
- (1)
- (2)
- (1)
- (3)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (2)
- (21)
- (13)
- (10)
- (4)
- (5)
- (1)
- (2)
- (15)
- (3)
- (4)
- (1)
- (2)
- (2)
- (2)
- (21,916)
- (13)
- (1)
- (714)
- (1)
- (9)
- (664)
- (5)
- (48)
- (2)
- (2)
- (378)
- (5)
- (4)
- (4)
- (9)
- (54)
- (3)
- (3)
- (3)
- (60)
- (7)
- (1)
- (4)
- (2)
- (5)
- (20,287)
- (111)
- (1)
- (1)
- (287)
- (17)
Filtered Search Results
| CAS | 133407-82-6 |
|---|
R&D Systems™ IL-17C Recombinant Protein Antigen
A Novus product, part of R&D Systems. Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
| CAS | 69558-55-0 |
|---|
| CAS | 12279-41-3 |
|---|
Invitrogen™ Alexa Fluor™ 647-DYKDDDDK Peptide
Alexa Fluor™ 647-DYKDDDDK Peptide
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Regulatory Status | RUO |
|---|---|
| Content And Storage | -30°C to -10°C |
| Purification Method | HPLC |
| Format | Powder |
| Product Type | Neurokinin A |
| Molecular Weight (g/mol) | 1133.33 |
| Common Name | Substance K |
| Sequence | His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 |
R&D Systems™ Lgr5/GPR49 Antibody Blocking Peptide
A Novus product, part of R&D Systems. Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
Invitrogen™ Human Estrogen Receptor alpha (aa 21-32) Synthetic Peptide
Synthetic Peptide
| Accession Number | P03372 |
|---|---|
| Regulatory Status | RUO |
| Purification Method | purified |
| Gene Alias | DKFZp686N23123; ER; Er alpha; ER36; ERa; ERalpha; ER-alpha; ERalpha protein; ESR; esr 1; Esr1; esr-1; ESRA; Estr; Estra; Estradiol receptor; estrogen nuclear receptor alpha; Estrogen receptor; estrogen receptor 1; estrogen receptor 1 (alpha); estrogen receptor alpha; estrogen receptor alpha c-terminus splice variant 1-2; estrogen receptor alpha E1-E2-1-2; estrogen receptor alpha E1-N2-E2-1-2; estrogen receptor alpha splice variant, CTERP-1; estrogen receptor alpha splice variant, ERalphaDup5; estrogen receptor alpha splice variant, ERalphai45a; estrogen receptor alpha splice variant, ERalphai45bL; estrogen receptor alpha splice variant, ERalphai45bS; estrogen receptor alpha splice variant, ERalphai45c; estrogen receptor alpha splice variant, ERalphai56; estrogen receptor alpha splice variant, ERalphai67; estrogen receptor alpha variant delta 4; estrogen receptor protein; estrogen receptor, alpha; ESTRR; hER-alpha36; I79_001166; Nr3a1; nuclear receptor; nuclear receptor subfamily 3 group A member 1; RNESTROR; RP1-130E4.1; unnamed protein product |
| Format | Lyophilized |
| Preservative | No preservative |
| Product Type | Peptide |
| Formulation | Peptide with no preservative |
| Common Name | Estrogen Receptor alpha |
| Gene Symbol | ESR1 |
| Concentration | 0.5 mg/mL |
| Species | Human |
| Lyophilized | Yes |
Invitrogen™ FL - PRIPRAP250 Peptide, 100μM
Fl - PRIPRAP250 peptide, 100μM
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Invitrogen™ FL - RIP140L6 Peptide, 100μM
Fl - RIP140L6 peptide, 100μM
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Invitrogen™ FL - SRC 3-1 Peptide, 100μM
Contains known interaction motifs and labeled with fluorescein. Invitrogen™ Fluorescein-SRC 3-1 Peptide, 100μM is matched to complement the LanthaScreen™ TR-FRET Nuclear Receptor Coregulator Assays to enable primary or secondary screening of nuclear receptor agonists and antagonists.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Regulatory Status | RUO |
|---|---|
| Purification Method | purified |
| Gene Alias | GFP; GFP tag; GFP2; green fluorescence; green fluorescent; Turbo eGFP |
| Format | Lyophilized |
| Preservative | No preservative |
| Product Type | Peptide |
| Formulation | Peptide with no preservative |
| Common Name | GFP |
| Concentration | 0.5 mg/mL |
| Species | Tag |
| Lyophilized | Yes |
Invitrogen™ Fluorescein-PGC1a Coactivator Peptide, 100 μM
Contains known interaction motifs and labeled with fluorescein. Invitrogen™ Fluorescein-PGC1a Coactivator Peptide, 100μM is matched to complement the LanthaScreen™ TR-FRET Nuclear Receptor Coregulator Assays to enable primary or secondary screening of nuclear receptor agonists and antagonists.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Shipping Condition | Dry Ice |
|---|---|
| Content And Storage | Store in freezer (-5 to -30°C). |
| Label Type | Classic Dyes |
| Accession Number | P01106 |
|---|---|
| Regulatory Status | RUO |
| Purification Method | purified |
| Gene Alias | AU016757; Avian myelocytomatosis viral (v-myc) oncogene homolog; avian myelocytomatosis viral oncogene homolog; bHLHe39; c Myc; class E basic helix-loop-helix protein 39; cmyc; c-Myc; c-myc epitope tag; c-myc proto-oncogene; mMyc; MRTL; Myc; Myc protein; Myc proto-oncogene protein; MYC proto-oncogene, bHLH transcription factor; Myc2; MYCC; myc-related translation/localization regulatory factor; myelocytomatosis oncogene; myelocytomatosis viral oncogene homolog; Niard; Nird; Proto-oncogene c-Myc; RNCMYC; Transcription factor p64; v-myc avian myelocytomatosis viral oncogene homolog; v-myc myelocytomatosis viral oncogene homolog; v-myc myelocytomatosis viral oncogene-like protein |
| Format | Lyophilized |
| Preservative | No preservative |
| Product Type | Peptide |
| Formulation | Peptide with no preservative |
| Common Name | c-Myc |
| Gene Symbol | MYC |
| Concentration | 0.5 mg/mL |
| Species | Human |
| Lyophilized | Yes |
| Accession Number | P16112 |
|---|---|
| Regulatory Status | RUO |
| Purification Method | purified |
| Gene Alias | ACAN; Agc; Agc1; AGCAN; aggrecan; aggrecan 1; aggrecan 1 (chondroitin sulfate proteoglycan 1, large aggregating proteoglycan, antigen identified by monoclonal antibody A0122); aggrecan core protein; Aggrecan core protein 2; aggrecan CS2 domain; aggrecan epidermal growth factor-like domain-1; aggrecan G2 domain; aggrecan interglobular domain; aggrecan keratan sulfate domain; aggrecan, structural proteoglycan of cartilage; articular cartilage aggrecan precursor; b2b183Clo; cartilage aggregating proteoglycan; cartilage-specific proteoglycan core protein; Chondroitin sulfate proteoglycan 1; chondroitin sulfate proteoglycan core protein 1; cmd; CSPCP; CSPG1; CSPGCP; high density cartilage proteoglycan; large aggregating cartilage proteoglycan core protein; large aggregating proteoglycan; large aggregating proteoglycan, antigen; MSK16; SEDK |
| Format | Lyophilized |
| Preservative | No preservative |
| Product Type | Peptide |
| Formulation | Peptide with no preservative |
| Common Name | Aggrecan |
| Gene Symbol | ACAN |
| Concentration | 0.5 mg/mL |
| Species | Human |
| Lyophilized | Yes |